SKI Market

Indian Indices

Nifty

25,149.85 -205.40
(-0.81%)

Sensex

82,500.47 -689.81
( -0.83%)

Bank Nifty

56,754.70 -201.30
( -0.35%)

Nifty IT

37,693.25 -683.40
( -1.78%)

Global Indices

Nasdaq

44,666.69 187.38
(0.42%)

Dow Jones

6,300.60 16.34
(0.26%)

Hang Seng

39,553.98 -92.38
(-0.23%)

Nikkei 225

8,941.12 -34.54
(-0.38%)

Forex

USD-INR

85.73 0.00
(0.00%)

EUR-INR

100.42 -0.13
(-0.13%)

GBP-INR

116.48 -0.10
(-0.08%)

JPY-INR

0.58 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5304659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

160.94

35.92

EPS(TTM)

Face Value()

Div & Yield %

0.16

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	2094.83	1888.16	1551.31	1197.40	1120.17	1139.82
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2094.83	1888.16	1551.31	1197.40	1120.17	1139.82
Other Income	45.11	56.72	20.55	32.96	54.00	55.83
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	2139.94	1944.88	1571.86	1230.36	1174.17	1195.65
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	12.05	9.24	6.14	6.57	7.72	8.74
Employee Cost	885.15	797.69	604.87	479.62	484.49	461.41
Other Manufacturing Expenses	100.59	106.58	64.68	48.82	44.20	34.40
Selling & Administrative Expenses	568.94	443.33	343.62	279.64	328.24	369.93
Miscellaneous Expenses	10.23	8.76	7.30	22.32	63.16	9.87
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1576.97	1365.58	1026.61	836.97	927.81	884.35
Operating Profit	562.97	579.30	545.26	393.39	246.36	311.29
Interest	19.19	16.57	16.77	19.00	18.45	0.77
Gross Profit	543.78	562.73	528.49	374.39	227.91	310.52
Depreciation	63.92	58.73	51.67	50.00	44.59	26.16
Profit Before Tax	479.86	504.00	476.82	324.39	183.32	284.36
Tax	123.83	129.05	121.54	87.77	58.46	81.01
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.01	-3.46	0.38	-2.18	1.28	-6.26
Reported Net Profit	357.04	378.40	354.90	238.79	123.57	209.61
Extraordinary Items	8.53	8.22	4.36	16.12	-32.96	1.05
Adjusted Net Profit	348.51	370.18	350.54	222.67	156.53	208.56
Adjustment below Net Profit	-39.81	-380.73	-371.29	-133.67	-252.35	3.06
P & L Balance brought forward	1186.66	1194.01	1214.88	1112.49	1209.68	1005.70
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	4.82	5.03	4.48	2.74	5.21	8.70
P & L Balance carried down	1499.07	1186.66	1194.01	1214.88	1075.69	1209.68
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	10.00	10.00	10.00	10.00
Dividend Per Share(Rs)	1.00	1.00	1.00	1.00	1.00	1.00
Earnings Per Share-Unit Curr	74.03	78.78	107.23	70.22	33.41	54.15
Earnings Per Share(Adj)-Unit Curr	74.03	78.78	71.49	46.81	22.27	36.10
Book Value-Unit Curr	313.56	241.25	354.86	347.77	300.49	337.05
Book Value(Adj)-Unit Curr	313.56	241.25	236.57	231.85	200.32	224.70

25,149.85 -205.40 (-0.81%)

82,500.47 -689.81 ( -0.83%)

56,754.70 -201.30 ( -0.35%)

37,693.25 -683.40 ( -1.78%)

44,666.69 187.38 (0.42%)

6,300.60 16.34 (0.26%)

39,553.98 -92.38 (-0.23%)

8,941.12 -34.54 (-0.38%)

85.73 0.00 (0.00%)

100.42 -0.13 (-0.13%)

116.48 -0.10 (-0.08%)

0.58 0.00 (-0.13%)